A recent mistrial in Tennessee has renewed questions about the Trump Administration initiative
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Editor
@IAM_Alerts This week's IAM Saturday Opinion - The UK will remain a key venue for biopharma patent litigants even when the UPC… https://t.co/BAq97cNWce Read more
@IAM_Alerts IAM platform use by geography and concentration since the start of the year. It's a very pleasing spread. Many than… https://t.co/aVYRPoYraq Read more
@IAM_Alerts More than 25 major companies have signed up to the US IP Alliance's innovation diversity pledge.… https://t.co/tWyPa99GJj Read more
@IAM_Alerts The story of Taiwanese biotech, JHL, shows why strategies for protecting proprietary know-how are essential in the… https://t.co/qSPYA5ad2I Read more